Released | Company | Title | Industry | Topic |
---|---|---|---|---|
27 Mar 2024 18:31 CET |
VRANKEN-POMMERY | VRANKEN-POMMERY MONOPOLE - RESULTATS ANNUELS 2023 - Progression du ROC de 12,7% à 39 M€ | 45101015 Distillers and Vintners | Income |
27 Mar 2024 18:30 CET |
WALLIX | WALLIX commits to Docaposte for a complete cybersecurity offer for SMEs, communities and health establishments | 10101015 Software | Legal |
27 Mar 2024 18:30 CET |
MEMSCAP REGPT | Memscap: 2023 Earnings | 10102010 Semiconductors | Income |
27 Mar 2024 18:30 CET |
WALLIX | WALLIX s'engage auprès de Docaposte pour une offre complète de cybersécurité à destination des PME, collectivités et établissements de santé | 10101015 Software | Legal |
27 Mar 2024 18:30 CET |
MEMSCAP REGPT | MEMSCAP : RESULTATS ANNUELS 2023 | 10102010 Semiconductors | Income |
27 Mar 2024 18:20 CET |
TARKETT | Tarkett- MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2023 | 50101035 Building Materials: Other | Corporate life |
27 Mar 2024 18:20 CET |
TARKETT | Tarkett- AVAILABILITY OF THE 2023 UNIVERSAL REGISTRATION DOCUMENT | 50101035 Building Materials: Other | Corporate life |
27 Mar 2024 18:06 CET |
B.C.P.-BCO COMERCIAL PORTUGUES | Corporate Governance Report 2023 | 30101010 Banks | Other subject |
27 Mar 2024 18:06 CET |
B.C.P.-BCO COMERCIAL PORTUGUES | Relatório do Governo Societário 2023 | 30101010 Banks | Other subject |
27 Mar 2024 18:06 CET |
LNA SANTE | LNA SANTE : Annual Results 2023 | 20101010 Health Care Facilities | General meeting / Board Meeting |
27 Mar 2024 18:03 CET |
HIGH CO | HIGHCO : Résultats Annuels 2023 | 40301020 Media Agencies | Income |
27 Mar 2024 18:03 CET |
HIGH CO | HighCo: 2023 annual earnings | 40301020 Media Agencies | Income |
27 Mar 2024 18:01 CET |
LNA SANTE | LNA SANTE : Résultats annuels 2023 | 20101010 Health Care Facilities | General meeting / Board Meeting |
27 Mar 2024 18:01 CET |
BIOMERIEUX | bioMérieux receives Dual 510(k) clearance and CLIA-waiver approval for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel | 20102010 Medical Equipment | Other subject |
27 Mar 2024 18:01 CET |
BIOMERIEUX | bioMérieux obtient l\'agrément 510(k) et la dérogation CLIA pour le panel BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) | 20102010 Medical Equipment | Other subject |
27 Mar 2024 18:00 CET |
LEPERMISLIBRE S.A. | lePERMISLIBRE publie ses résultats annuels 2023 | 40201070 Consumer Services: Misc. | Commercial results |
27 Mar 2024 18:00 CET |
LEPERMISLIBRE S.A. | lePERMISLIBRE announces its 2023 annual results | 40201070 Consumer Services: Misc. | Commercial results |
27 Mar 2024 18:00 CET |
ABIVAX | ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 29.02.24. | 20103010 Biotechnology | Share history |
27 Mar 2024 18:00 CET |
ENOGIA | ENOGIA: 2023 annual results | 60102020 Renewable Energy Equipment | Income |
27 Mar 2024 18:00 CET |
ENOGIA | ENOGIA: Résultats annuels 2023 | 60102020 Renewable Energy Equipment | Income |
27 Mar 2024 18:00 CET |
VAN DE VELDE | VAN DE VELDE : acquisition of treasury shares | 40204020 Clothing and Accessories | Other subject |
27 Mar 2024 18:00 CET |
AMG Critical Materials N.V. | AMG Critical Materials N.V. Publishes Agenda for the 2024 Annual General Meeting and Expands Management Board | 50204000 Machinery: Industrial | - |
27 Mar 2024 18:00 CET |
EXPLOSIFS PROD.CHI | Forte amélioration des résultats, situation financière saine et reprise du dividende | 55201000 Chemicals: Diversified | Sales, Income, Commercial results |
27 Mar 2024 18:00 CET |
OSE IMMUNOTHERAPEUTICS | OSE Immunotherapeutics Reports Full Year 2023 Financial Results and Provides Business Strategy Update | 20103010 Biotechnology | Income |
27 Mar 2024 18:00 CET |
GUILLEMOT | GUILLEMOT CORPORATION: 2023 ANNUAL RESULTS | 10102030 Computer Hardware | General meeting / Board Meeting |
27 Mar 2024 18:00 CET |
VALEO | Valeo General Shareholders' Meeting 2024 | 40101025 Auto Parts | General meeting / Board Meeting |
27 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis LTIP Share Buyback Program 2024 – Update | 55201000 Chemicals: Diversified | Other subject |
27 Mar 2024 18:00 CET |
AZELIS GROUP NV | Azelis LTIP Aandeleninkoopprogramma 2024 - update | 55201000 Chemicals: Diversified | Other subject |
27 Mar 2024 18:00 CET |
HYBRID SOFTWARE GROUP PLC | Notification of transactions in shares by persons discharging managerial responsibility ("PDMRs") | 10101015 Software | Other subject |
27 Mar 2024 18:00 CET |
SCHLUMBERGER | SLB Announces First-Quarter 2024 Results Conference Call | 60101030 Oil Equipment and Services | Meetings / events |
27 Mar 2024 18:00 CET |
VAN DE VELDE | VAN DE VELDE : inkoop eigen aandelen | 40204020 Clothing and Accessories | Other subject |
27 Mar 2024 18:00 CET |
OSE IMMUNOTHERAPEUTICS | OSE Immunotherapeutics publie ses résultats financiers annuels 2023 et fait le point sur sa stratégie de développement | 20103010 Biotechnology | Income |
27 Mar 2024 18:00 CET |
CONSTRUCTEURS BOIS | FORTE CROISSANCE DE L'ACTIVITÉ ET DE LA RENTABILITÉ EN 2023 - RELÈVEMENT DE L'OBJECTIF DE CHIFFRE D'AFFAIRES 2025 | 50101010 Construction | Sales, Income, Commercial results |
27 Mar 2024 18:00 CET |
VALEO | Assemblée générale 2024 de Valeo | 40101025 Auto Parts | General meeting / Board Meeting |
27 Mar 2024 18:00 CET |
MEDINCELL S.A. | MedinCell to Present at the 23rd Annual Needham Virtual Healthcare Conference | 20103010 Biotechnology | Corporate life |
27 Mar 2024 18:00 CET |
GUILLEMOT | GUILLEMOT CORPORATION : RESULTATS ANNUELS 2023 | 10102030 Computer Hardware | General meeting / Board Meeting |
27 Mar 2024 18:00 CET |
MEXEDIA S.P.A | Results 2023 | 30202000 Diversified Financial Services | Commercial results |
27 Mar 2024 18:00 CET |
MEDINCELL S.A. | MedinCell participera à la 23ème conférence annuelle Needham Virtual Healthcare | 20103010 Biotechnology | Corporate life |
27 Mar 2024 17:45 CET |
INVIBES ADVERTISING N.V. | Invibes Advertising : Forte progression des résultats annuels 2023. | 40301020 Media Agencies | Commercial results |
27 Mar 2024 17:45 CET |
INVIBES ADVERTISING N.V. | Invibes Advertising : Strong growth in annual results 2023. | 40301020 Media Agencies | Commercial results |
27 Mar 2024 17:45 CET |
ARGAN | ARGAN delivered a 4,600 sq.m, Aut0nom®-labelled distribution centre to DSV in Normandie | 35102030 Office REITs | New |
27 Mar 2024 17:45 CET |
INVIBES ADVERTISING N.V. | Invibes Advertising : Strong growth in annual results 2023. Return to positive EBITDA and net profit. | 40301020 Media Agencies | Sales, Income, Commercial results |
27 Mar 2024 17:45 CET |
KLEPIERRE | KLÉPIERRE: AVAILABILITY OF 2023 UNIVERSAL REGISTRATION DOCUMENT | 35102045 Retail REITs | Other subject |
27 Mar 2024 17:45 CET |
INVIBES ADVERTISING N.V. | Invibes Advertising : Forte progression des résultats annuels 2023. Retour à un EBITDA et à un résultat net positifs. | 40301020 Media Agencies | Sales, Income, Commercial results |
27 Mar 2024 17:45 CET |
TRANSGENE | Transgene anticipates significant progress from immunotherapy pipeline in 2024 and extends financial visibility until Q4 2025 | 20103010 Biotechnology | Income |
27 Mar 2024 17:45 CET |
MAUNA KEA TECHNOLOGIES S.A. | Mauna Kea Technologies s’associe à V7 pour le développement d’applications innovantes d’IA avec le Cellvizio | 20102010 Medical Equipment | Alliances and agreements |
27 Mar 2024 17:45 CET |
TRANSGENE | Transgene nomme Lucie Larguier en tant que Directrice Financière et Christelle Schwoerer Comme Directrice des Ressources Humaines | 20103010 Biotechnology | Journal / appointments |
27 Mar 2024 17:45 CET |
CEGEDIM | Cegedim Full year 2023 results: Revenue and recurring operating income both up | 10101010 Computer Services | Income |
27 Mar 2024 17:45 CET |
ARGAN | ARGAN livre à DSV une plateforme de distribution de 4 600 m² labellisée Aut0nom® en Normandie | 35102030 Office REITs | New |
27 Mar 2024 17:45 CET |
KLEPIERRE | KLÉPIERRE: MISE À DISPOSITION DU DOCUMENT D'ENREGISTREMENT UNIVERSEL 2023 | 35102045 Retail REITs | Other subject |